Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156637 · ClinicalTrials.gov registry record · NA
A Study of Strategies to Improve Schizophrenia Treatment
A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 4
- Study locations
NCT00156637: Completed NA study of Schizophrenia and Schizoaffective Disorder, sponsored by US Department of Veterans Affairs.
NCT00156637 is a NA study of Schizophrenia and Schizoaffective Disorder that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 106 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (52% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00156637, a NA study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this project is to translate research findings about key aspects of antipsychotic treatment into routine care through a multi-component intervention, focusing on improving two aspects of medication management that are directly linked to patient outcomes: 1) monitoring for potentially serious metabolic side effects of newer antipsychotic medication, and 2) increasing the appropriate use of clozapine for treatment-refractory patients.
Conditions Studied
Interventions
- BEHAVIORAL Team-Based Quality Improvement Intervention
- BEHAVIORAL Opinion Leader Intervention
- BEHAVIORAL Team Based Quality Improvement
Study Locations (4)
Arkansas
- Veterans Health Care System of the Ozarks, Fayetteville, AR - Fayetteville
- Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR - No. Little Rock
Ohio
- Dayton VA Medical Center, Dayton, OH - Dayton
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-03 |
| Phase | NA |
What the finished NCT00156637 record still lists
NCT00156637 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (52% lower).
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 3 interventions - of which Team-Based Quality Improvement Intervention is the first listed.
NCT00156637 reports a single indexed study location in Arkansas, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT00156637 about?
NCT00156637 is a clinical study titled "A Study of Strategies to Improve Schizophrenia Treatment". The goal of this project is to translate research findings about key aspects of antipsychotic treatment into routine care through a multi-component intervention, focusing on improving two aspects of medication management that are directly linked to patient outcomes: 1) monitoring for potentially ser...
What is the current status of trial NCT00156637?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2005-06. Estimated completion is 2008-03.
What conditions does trial NCT00156637 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.
What interventions are being tested in trial NCT00156637?
The interventions under investigation include: Team-Based Quality Improvement Intervention (BEHAVIORAL), Opinion Leader Intervention (BEHAVIORAL), Team Based Quality Improvement (BEHAVIORAL).
Who is sponsoring clinical trial NCT00156637?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00156637 being conducted?
This trial has 4 study locations across Arkansas, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00156637's enrollment target sits among peer trials
106 133rd of 315 higher than 183 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia